What is the incremental market of new medical infrastructure?
On March 24, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) ( Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) . SZ) said in response to investors’ questions on the interactive platform that in China, large cities represented by Beijing, Shanghai, Guangzhou and Shenzhen have set off a wave of expansion of large hospitals, and the increment brought by the expansion has played a positive role in the company. With the gradual participation of large hospitals in other cities, China’s new infrastructure business opportunities will continue to increase. In view of the lingering threat of the epidemic and the basic availability of funds for construction, all parts of the country have begun to accelerate the implementation of capacity expansion projects of public hospitals. However, the construction of the hospital is not overnight. It is expected that the new medical infrastructure will last for at least three years.
Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) also responded whether there is any plan to enter the field of second-generation sequencing Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) said that the company has no plan to lay out second-generation sequencing. Before the epidemic, the company has begun to pay close attention to the field of molecular diagnosis. With the birth of the epidemic, the market scale of molecular diagnosis will be expanded for a long time. The company is very optimistic about the future growth potential of the business and will actively accelerate the R & D layout of molecular diagnosis.
Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) was founded in 1991 and listed in 2018. Headquartered in Shenzhen, it is mainly engaged in the R & D, manufacturing, marketing and service of medical devices. Its main business covers three fields: life information and support, in vitro diagnosis and medical imaging.
As of the closing on March 24, Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) reported 315 yuan, up 1.68%, with a market value of 381.9 billion yuan.
